Details
Stereochemistry | ACHIRAL |
Molecular Formula | C23H26Cl2O6 |
Molecular Weight | 469.355 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(OC1=CC=C(Cl)C=C1)C(=O)OCCCOC(=O)C(C)(C)OC2=CC=C(Cl)C=C2
InChI
InChIKey=JLRNKCZRCMIVKA-UHFFFAOYSA-N
InChI=1S/C23H26Cl2O6/c1-22(2,30-18-10-6-16(24)7-11-18)20(26)28-14-5-15-29-21(27)23(3,4)31-19-12-8-17(25)9-13-19/h6-13H,5,14-15H2,1-4H3
DescriptionSources: http://www.genome.jp/dbget-bin/www_bget?D01212Curator's Comment: Description was created based on several sources, including http://link.springer.com.sci-hub.cc/article/10.1007/BF03286654
Sources: http://www.genome.jp/dbget-bin/www_bget?D01212
Curator's Comment: Description was created based on several sources, including http://link.springer.com.sci-hub.cc/article/10.1007/BF03286654
Simfibrate, a derivative of clofibrate, is a hypolipidemic drug, that lowers serum chlolesterol and triglycerids. Under the brand name Cholesolvin it is indicated for hyperlipidaemia associated with arteriosclerosis, cerebral atherosclerosis, coronary arteriosclerosis, hypertension, diabetes.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: WP266 Sources: http://www.genome.jp/dbget-bin/www_bget?D01212 |
|||
Target ID: WP3481 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6417824 |
|||
Target ID: WP197 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6417824 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Cholesolvin Approved UseIndications: hyperlipidaemia associated with arteriosclerosis, cerebral atherosclerosis, coronary arteriosclerosis, hypertension, diabetes. |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6417824
1.5 g/day P.O
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
C10AB06
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
||
|
NCI_THESAURUS |
C98150
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
||
|
WHO-VATC |
QC10AB06
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB10527MIG
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
PRIMARY | |||
|
2444
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
PRIMARY | |||
|
5217
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
PRIMARY | |||
|
100000083535
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
PRIMARY | |||
|
14929-11-4
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
PRIMARY | |||
|
SIMFIBRATE
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
PRIMARY | |||
|
m9945
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
PRIMARY | Merck Index | ||
|
C72998
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
PRIMARY | |||
|
DB13433
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
PRIMARY | |||
|
2732
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
PRIMARY | |||
|
238-998-7
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
PRIMARY | |||
|
DTXSID8057647
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105435
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
PRIMARY | |||
|
L2R75RQX26
Created by
admin on Fri Dec 15 16:18:45 GMT 2023 , Edited by admin on Fri Dec 15 16:18:45 GMT 2023
|
PRIMARY |
ACTIVE MOIETY